Holding(s) in Company

Summary by AI BETAClose X

Bluestem Asset Management, LLC, through its general partner Bluestem Partners, LP, has reduced its voting rights in RTW Biotech Opportunities Ltd to 9.96%, down from a previous holding of 10.14%. This change, effective May 5, 2026, represents an acquisition or disposal of voting rights, with Michael D. Bills holding sole authority for Bluestem Asset Management, LLC. The total number of voting rights held in the issuer is 32,250,831, with no voting rights held through financial instruments.

Disclaimer*

UK 100

Latest directors dealings